Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01661972
Title Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer
Acronym X-TRAP
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors John Strickler, M.D.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duke Cancer Center, Duke University Medical Center Durham North Carolina 27710 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field